Form 4 Tracker
ORBIMED ADVISORS LLC

10% Owner; Director; Director, 10% Owner · 14 filings · Latest: Jun 22, 2026

Adicet Bio, Inc.
Enliven Therapeutics, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ELVN
ORBIMED ADVISORS LLC10% OwnerJun 22, 2026
Sale
$45.36860,123$39.0M6,555,102
ELVN
OrbiMed Genesis Master Fund, L.P.Jun 22, 2026
Proposed Sale
$45.9626,323$1.2M
ELVN
OrbiMed Private Investments VII, LPJun 22, 2026
Proposed Sale
$45.96833,800$38.3M
ELVN
ORBIMED ADVISORS LLC10% OwnerJun 15, 2026
Sale
$45.02281,408$12.7M7,388,902
ELVN
OrbiMed Private Investments VII, LPJun 15, 2026
Proposed Sale
$42.36272,322$11.5M
ELVN
OrbiMed Genesis Master Fund, L.P.Jun 15, 2026
Proposed Sale
$42.369,086$384.9K
QTTB
ORBIMED ADVISORS LLCDirector, 10% OwnerMay 28, 2026
Purchase
$8.001,875,000$15.0M625,000
SION
OrbiMed Private Investments VIII, LPMay 29, 2026
Proposed Sale
$42.82210,876$9.0M
SION
ORBIMED ADVISORS LLCDirectorMay 27, 2026
Sale
$44.49101$4.5K2,671,721
SION
OrbiMed Private Investments VIII, LPMay 29, 2026
Proposed Sale
$42.801,082,480$46.3M
SION
ORBIMED ADVISORS LLCDirectorMay 11, 2026
Sale
$46.22184,639$8.5M2,671,822
SION
ORBIMED ADVISORS LLCDirectorMay 8, 2026
Sale
$44.5859,767$2.7M2,856,461
SION
ORBIMED ADVISORS LLCDirectorMay 7, 2026
Sale
$44.6148,546$2.2M2,916,228
TRAW
ORBIMED ADVISORS LLC10% OwnerApr 16, 2026
Purchase
$1.67597,729$998.2K1,203,250
PRLD
ORBIMED ADVISORS LLCDirector, 10% OwnerApr 21, 2026
Purchase
$4.442,815,315$12.5M1,126,126
SION
ORBIMED ADVISORS LLCDirectorApr 18, 2026
Sale
$44.522,948$131.2K2,964,774
SION
ORBIMED ADVISORS LLCDirectorApr 17, 2026
Sale
$44.6852,397$2.3M2,967,722
SION
ORBIMED ADVISORS LLCDirectorApr 16, 2026
Sale
$45.34226,906$10.3M3,020,119
SION
ORBIMED ADVISORS LLCDirectorApr 15, 2026
Sale
$44.64235,863$10.5M3,247,025
SION
ORBIMED ADVISORS LLCDirectorApr 14, 2026
Sale
$44.5147,814$2.1M3,482,888

Page 1 of 3

Next →